Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
Universität Hamburg · University Medical Center Hamburg-Eppendorf · +1 more institution
Abstract
Five risk factors account for approximately 50% of the global burden of cardiovascular disease. How the presence or absence of classic risk factors affects lifetime estimates of cardiovascular disease and death from any cause remains unclear.
We harmonized individual-level data from 2,078,948 participants across 133 cohorts, 39 countries, and 6 continents. Lifetime risk of cardiovascular disease and death from any cause was estimated up to 90 years of age according to the presence or absence of arterial hypertension, hyperlipidemia, underweight and overweight or obesity, diabetes, and smoking at 50 years of age. Differences in life span (in terms of additional life-years free of cardiovascular disease or death from any cause) according to the presence or absence of these risk factors were also estimated. Risk-factor trajectories were analyzed to predict lifetime differences according to risk-factor variation.
Citation impact
- FWCI
- 92.92
- Percentile
- 100%
- References
- 17
Authors
1- TGThe Global Cardiovascular Risk ConsortiumCorresponding
Universität Hamburg, University Medical Center Hamburg-Eppendorf, German Centre for Cardiovascular Research
Topics & keywords
- Medicine
- Environmental health
- Risk analysis (engineering)
- Internal medicine
- Cardiology
- Good health and well-being
Funding
- UDU.S. Department of Veterans Affairs
- CRCancer Research Institute
- EUEmory University
- HHHamilton Health Sciences
- UJUniwersytet Jagielloński Collegium Medicum
- UBUniversiti Brunei Darussalam
- NTNorges Teknisk-Naturvitenskapelige Universitet
- LSLondon School of Hygiene and Tropical Medicine
- MUMcMaster University
- DZDeutsches Zentrum für Herz-Kreislaufforschung
- COCollege of Pharmacy, University of Georgia
- ECEuropean CommissionAwards: Biomed, BMH4-CT98-3183, FP7, HEALTH-F3-2010-242244, FP7, HEALTH-F4-2007-201413, FP7, HEALTH-F2-2011-278913, FP5, QLG2-CT-2002-01254
- SASouth African Medical Research Council
- PHPublic Health Foundation of India
- UOUniversity of New South Wales
- CNChonnam National University
- SNSeoul National University
- UDUniversità degli Studi di Milano-Bicocca
- SBSiberian Branch, Russian Academy of Sciences
- LULunds Universitet
- UNUniversidad Nacional de La Plata
- JGJohannes Gutenberg-Universität Mainz
- QUQatar University
- TATel Aviv University
- TUTehran University of Medical Sciences and Health Services
- MUMashhad University of Medical Sciences
- BKB.P. Koirala Institute of Health Sciences
- ITInstituto Tecnológico y de Estudios Superiores de Monterrey
- NUNorth-West University
- UIUniversitetet i Oslo
- TUTechnische Universität München
- LMLudwig-Maximilians-Universität München
- SBShahid Beheshti University of Medical Sciences
- UUUppsala Universitet
- TÜTartu Ülikool
- UUUniversität Ulm
- FOFaculty of Health and Medical Sciences, University of Western Australia
- HUHarokopio University
- FMFakultet Medicinskih Nauka, Univerziteta U Kragujevcu
- AUAkershus Universitetssykehus
- BHBaker Heart and Diabetes Institute
- INInstituto Nacional De Salud Pública
- BHBispebjerg Hospital
- CICardio-Pulmonary Institute
- SOSchool of Medicine, Emory University
- COCollege of Medicine, Seoul National University
- MRMedical Research CouncilAward: G0601463, No. 80983
- CCCancer Council Victoria
- RARussian Academy of Sciences
- DSDet Sundhedsvidenskabelige Fakultet, Københavns Universitet
- RIResearch Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
- H2Horizon 2020Awards: Horizon 2020, No. 825903, Horizon 2020, No. 847770
- EUErasmus Universitair Medisch Centrum Rotterdam
- HZHelmholtz Zentrum München